泰德医药（浙江）股份有限公司（03880）于2026年3月4日发布2026年2月股份变动月报表。报告期为2026年2月1日至2026年2月28日，公司股本结构资料如下：
公司已发行股本中，H股数量为73,598,888股，非上市股份数量为68,201,112股，两部分合计已发行股本为141,800,000股。报告期内，公司未进行任何新增发行、回购或注销股份，也无库藏股变动。
截至2026年2月28日，公司已发行股本总数维持不变。公司在公告中确认，相关股份事项均严格遵守香港联合交易所有限公司证券上市规则及相关法律法规。该月报表由公司联席公司秘书吴东澄签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.